IAPP and type 2 diabetes mellitus: In addition, other pathological processes, including chronic inflammation, incretin dysregulation, hyperglucagonemia, lipolysis, central appetite dysregulation, abnormal gastric emptying, gut dysbiosis, and islet amyloid polypeptide (IAPP) deposition, are also regarded as key regulators in the pathophysiology of T2DM.1